Viemed Healthcare, Inc. (VMD): Gross Profit
$155.46M
Year ended 2025-12-31
$173.32M
Trailing 12 months to 2026-06-30
+22.4%
3-year compound annual growth
+14.2%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $155.46M | +16.7% | 2026-03-04, From 2025-01-01 |
| 2024-12-31 | $133.20M | +18.1% | 2026-03-04, From 2024-01-01 |
| 2023-12-31 | $112.78M | +33.2% | 2026-03-04, From 2023-01-01 |
| 2022-12-31 | $84.68M | +15.4% | 2025-03-10, From 2022-01-01 |
| 2021-12-31 | $73.41M | -8.4% | 2023-03-02, From 2021-01-01 |
| 2020-12-31 | $80.11M | +43.0% | 2022-03-07, From 2020-01-01 |
| 2019-12-31 | $56.01M | +17.2% | 2021-03-03, From 2019-01-01 |
| 2018-12-31 | $47.77M | n/a | 2020-03-04, From 2018-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Viemed Healthcare, Inc. (VMD) | 2025-12-31 | $155.46M | +16.7% |
| Sotera Health Co (SHC) | 2025-12-31 | $645.53M | +7.2% |
| Progyny, Inc. (PGNY) | 2025-12-31 | $304.48M | +20.2% |
| Cryo Cell International Inc (CCEL) | 2025-11-30 | $24.19M | +0.6% |
| Mangoceuticals, Inc. (MGRX) | 2025-12-31 | $250.4K | -34.1% |
| BioRestorative Therapies, Inc. (BRTX) | 2025-12-31 | $335.9K | -9.9% |
Compare VMD, SHC, PGNY, CCEL side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗